Table 4.

Relationship between TG/HDL-C ratio and the incident GDM in different models.

Variable	Crude model (OR.,95% CI, P)	Model I (OR,95% CI, P)	Model II (OR,95% CI, P)	Model III (OR,95% CI, P)
TG/HDL-C ratio	2.24 (1.68, 2.98) <0.0001	2.10 (1.55, 2.85) <0.0001	1.77 (1.32, 2.38) 0.0001	1.85 (1.35, 2.52) 0.0001
TG/HDL-C ratio (tertile)
Q1	Ref.	Ref.	Ref.	Ref.
Q2	2.40 (0.61, 9.40) 0.2104	1.86 (0.45, 7.64) 0.3922	2.00 (0.41, 9.71) 0.3902	1.41 (0.27, 7.35) 0.6849
Q3	10.27 (3.06, 34.44) 0.0002	7.54 (2.17, 26.23) 0.0015	4.38 (1.05, 18.29) 0.0429	4.75 (1.12, 20.07) 0.0341
P for trend	<0.0001	0.0001	0.0202	0.0108

Crude model: we did not adjust other covariants.

Model I: we adjusted age, pre-pregnancy BMI, parity.

Model II: we adjusted age, pre-pregnancy BMI, parity, hepatic steatosis, AST, GGT, ALT, TC, LDL-C, HOMA-IR, adiponectin.

Model III: we adjusted age(smooth), pre-pregnancy BMI(smooth), parity, hepatic steatosis, AST(smooth), GGT(smooth), ALT(smooth), TC(smooth), LDL-C(smooth), HOMA-IR(smooth), adiponectin(smooth).

HR, Hazard ratios; CI: confidence, Ref: reference; eGFR, evaluated glomerular filtration rate(mL/min·1.73 m2); NAFLD, non-alcoholic fatty liver disease.

OR, odds ratios; CI, confidence interval; Ref, Reference; TG/HDL-C ratio, triglyceride to high-density lipoprotein cholesterol ratio.